US5721268A
(en)
|
1991-09-23 |
1998-02-24 |
Florida State University |
C7 taxane derivatives and pharmaceutical compositions containing them
|
FR2698871B1
(fr)
|
1992-12-09 |
1995-02-24 |
Rhone Poulenc Rorer Sa |
Nouveau taxoïdes, leur préparation et les compositions pharmaceutiques qui les contiennent.
|
US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
US20070117863A1
(en)
*
|
1993-02-22 |
2007-05-24 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
US20030073642A1
(en)
*
|
1993-02-22 |
2003-04-17 |
American Bioscience, Inc. |
Methods and formulations for delivery of pharmacologically active agents
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
US20030068362A1
(en)
*
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
US6096331A
(en)
*
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
EP1632259B1
(de)
*
|
1993-07-19 |
2011-12-21 |
Angiotech Pharmaceuticals, Inc. |
Anti-Angiogene Mittel und Verfahren zu deren Verwendung
|
US5994341A
(en)
*
|
1993-07-19 |
1999-11-30 |
Angiogenesis Technologies, Inc. |
Anti-angiogenic Compositions and methods for the treatment of arthritis
|
FR2718963B1
(fr)
*
|
1994-04-25 |
1996-05-24 |
Rhone Poulenc Rorer Sa |
Nouvelle composition pharmaceutique à base de taxoïdes.
|
US5534499A
(en)
*
|
1994-05-19 |
1996-07-09 |
The University Of British Columbia |
Lipophilic drug derivatives for use in liposomes
|
DE4430593C2
(de)
*
|
1994-08-20 |
1999-01-14 |
Max Delbrueck Centrum |
Verfahren zur Herstellung von Liposomal verkapseltem Taxol
|
US5851548A
(en)
*
|
1995-06-07 |
1998-12-22 |
Gen-Probe Incorporated |
Liposomes containing cationic lipids and vitamin D
|
US5756352A
(en)
*
|
1995-06-07 |
1998-05-26 |
Gen-Probe Incorporated |
Thiocationic lipid-nucleic acid conjugates
|
US5711964A
(en)
*
|
1995-06-07 |
1998-01-27 |
United States Of America |
Method for the intracellular delivery of biomolecules using liposomes containing cationic lipids and vitamin D
|
US5759519A
(en)
*
|
1995-06-07 |
1998-06-02 |
Gen-Probe Incorporated |
Method for the intracellular delivery of biomolecules using thiocationic lipids
|
DE19605024A1
(de)
*
|
1996-01-31 |
1997-08-07 |
Schering Ag |
Neue selektive Taxane, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
|
EP0932399B1
(de)
*
|
1996-03-12 |
2006-01-04 |
PG-TXL Company, L.P. |
Wasserlösliche paclitaxel-prodrogen
|
US6441025B2
(en)
|
1996-03-12 |
2002-08-27 |
Pg-Txl Company, L.P. |
Water soluble paclitaxel derivatives
|
KR20000015944A
(ko)
|
1996-05-24 |
2000-03-15 |
팜 윌리암 엔. |
신체 통로의 질병을 치료 또는 예방하기 위한조성물 및 방법
|
WO1998018492A1
(fr)
*
|
1996-10-25 |
1998-05-07 |
Yoshitomi Pharmaceutical Industries Ltd. |
Procede pour empecher la precipitation de medicaments
|
US6458373B1
(en)
*
|
1997-01-07 |
2002-10-01 |
Sonus Pharmaceuticals, Inc. |
Emulsion vehicle for poorly soluble drugs
|
US5827533A
(en)
*
|
1997-02-06 |
1998-10-27 |
Duke University |
Liposomes containing active agents aggregated with lipid surfactants
|
US7112338B2
(en)
*
|
1997-03-12 |
2006-09-26 |
The Regents Of The University Of California |
Cationic liposome delivery of taxanes to angiogenic blood vessels
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
JP4865937B2
(ja)
*
|
1997-06-27 |
2012-02-01 |
アブラクシス バイオサイエンス、エルエルシー |
パクリタキセル製剤
|
US5925776A
(en)
*
|
1997-12-24 |
1999-07-20 |
Schein Pharmacetical, Inc. |
Polyethoxylated castor oil, process of making the same and formulations thereof
|
US7208011B2
(en)
|
2001-08-20 |
2007-04-24 |
Conor Medsystems, Inc. |
Implantable medical device with drug filled holes
|
US7208010B2
(en)
|
2000-10-16 |
2007-04-24 |
Conor Medsystems, Inc. |
Expandable medical device for delivery of beneficial agent
|
US20040254635A1
(en)
*
|
1998-03-30 |
2004-12-16 |
Shanley John F. |
Expandable medical device for delivery of beneficial agent
|
US6241762B1
(en)
|
1998-03-30 |
2001-06-05 |
Conor Medsystems, Inc. |
Expandable medical device with ductile hinges
|
TR200003435T2
(tr)
|
1998-05-20 |
2001-03-21 |
The Liposome Company,Inc. |
Yeni parçacıklı formülasyonlar
|
US7314637B1
(en)
|
1999-06-29 |
2008-01-01 |
Neopharm, Inc. |
Method of administering liposomal encapsulated taxane
|
US6146659A
(en)
*
|
1998-07-01 |
2000-11-14 |
Neopharm, Inc. |
Method of administering liposomal encapsulated taxane
|
US6461637B1
(en)
*
|
2000-09-01 |
2002-10-08 |
Neopharm, Inc. |
Method of administering liposomal encapsulated taxane
|
US6293967B1
(en)
|
1998-10-29 |
2001-09-25 |
Conor Medsystems, Inc. |
Expandable medical device with ductile hinges
|
WO2000067760A1
(fr)
*
|
1999-05-11 |
2000-11-16 |
Sankyo Company, Limited |
Preparation de liposomes a base de medicaments antitumoraux liposolubles
|
US6290673B1
(en)
|
1999-05-20 |
2001-09-18 |
Conor Medsystems, Inc. |
Expandable medical device delivery system and method
|
TW422706B
(en)
|
1999-07-01 |
2001-02-21 |
Wang Iz Rung |
An oil-in-water emulsion type of paclitaxel
|
DE60027730T2
(de)
*
|
1999-09-09 |
2007-03-29 |
The Regents Of The University Of California, Oakland |
Verabreichung von taxanen an angiogene blutgefässe mittels kationischer liposomen
|
EP1229934B1
(de)
|
1999-10-01 |
2014-03-05 |
Immunogen, Inc. |
Zusammensetzungen und verfahren zur behandlung von krebs mittels immunkonjugaten und chemotherapeutischen agenzien
|
US6348215B1
(en)
|
1999-10-06 |
2002-02-19 |
The Research Foundation Of State University Of New York |
Stabilization of taxane-containing dispersed systems
|
US20040009229A1
(en)
*
|
2000-01-05 |
2004-01-15 |
Unger Evan Charles |
Stabilized nanoparticle formulations of camptotheca derivatives
|
CO5280224A1
(es)
*
|
2000-02-02 |
2003-05-30 |
Univ Florida State Res Found |
Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
|
DE60123583T2
(de)
*
|
2000-02-04 |
2007-08-09 |
Lipoxen Technologies Ltd. |
Dehydratisierungs-/rehydratisierungsverfahren zur herstellung von liposome
|
US20020077290A1
(en)
|
2000-03-17 |
2002-06-20 |
Rama Bhatt |
Polyglutamic acid-camptothecin conjugates and methods of preparation
|
AU2001253336A1
(en)
|
2000-04-10 |
2001-10-23 |
Teva Pharmaceutical Industries Ltd. |
Method 0f administration of paclitaxel-plasma protein formulation
|
US6589968B2
(en)
|
2001-02-13 |
2003-07-08 |
Kosan Biosciences, Inc. |
Epothilone compounds and methods for making and using the same
|
US7485320B2
(en)
*
|
2000-09-25 |
2009-02-03 |
Industrial Technology Research Institute |
Liposome for incorporating large amounts of hydrophobic substances
|
US6764507B2
(en)
|
2000-10-16 |
2004-07-20 |
Conor Medsystems, Inc. |
Expandable medical device with improved spatial distribution
|
DE60112318T4
(de)
|
2000-10-16 |
2008-11-27 |
Conor Medsystems, Inc., Menlo Park |
Ausdehnbare medizinische Vorrichtung zur Abgabe eines nützlichen Agens
|
AU2877202A
(en)
|
2000-11-02 |
2002-05-15 |
Sloan Kettering Inst Cancer |
Methods for enhancing the efficacy of cytotoxic agents through the use of hsp90 inhibitors
|
US6610322B1
(en)
*
|
2000-12-20 |
2003-08-26 |
Brian Charles Keller |
Self forming, thermodynamically stable liposomes and their applications
|
US8067032B2
(en)
*
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US7115565B2
(en)
|
2001-01-18 |
2006-10-03 |
Pharmacia & Upjohn Company |
Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
|
US6964680B2
(en)
*
|
2001-02-05 |
2005-11-15 |
Conor Medsystems, Inc. |
Expandable medical device with tapered hinge
|
US20040073294A1
(en)
*
|
2002-09-20 |
2004-04-15 |
Conor Medsystems, Inc. |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
US6893859B2
(en)
|
2001-02-13 |
2005-05-17 |
Kosan Biosciences, Inc. |
Epothilone derivatives and methods for making and using the same
|
ATE440593T1
(de)
*
|
2001-03-27 |
2009-09-15 |
Phares Pharm Res Nv |
Verfahren und zusammensetzung zur solubilisierung einer biologisch wirksamen verbindung mit geringer wasserlíslichkeit
|
US7029695B2
(en)
*
|
2001-07-10 |
2006-04-18 |
Telik, Inc. |
Therapeutic compositions containing glutathione analogs
|
CA2354486A1
(en)
*
|
2001-07-31 |
2003-01-31 |
Florida State University Research Foundation, Inc. |
C7 ester substituted taxanes
|
SG125889A1
(en)
*
|
2001-08-01 |
2006-10-30 |
Univ Florida State Res Found |
C7 ester subsituted taxanes
|
US20090197852A9
(en)
*
|
2001-08-06 |
2009-08-06 |
Johnson Robert G Jr |
Method of treating breast cancer using 17-AAG or 17-AG or a prodrug of either in combination with a HER2 inhibitor
|
US20040249443A1
(en)
*
|
2001-08-20 |
2004-12-09 |
Shanley John F. |
Expandable medical device for treating cardiac arrhythmias
|
US7056338B2
(en)
|
2003-03-28 |
2006-06-06 |
Conor Medsystems, Inc. |
Therapeutic agent delivery device with controlled therapeutic agent release rates
|
US20050191359A1
(en)
*
|
2001-09-28 |
2005-09-01 |
Solubest Ltd. |
Water soluble nanoparticles and method for their production
|
US20050249786A1
(en)
*
|
2001-09-28 |
2005-11-10 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of amorphous compounds
|
US6878693B2
(en)
*
|
2001-09-28 |
2005-04-12 |
Solubest Ltd. |
Hydrophilic complexes of lipophilic materials and an apparatus and method for their production
|
US20050227911A1
(en)
*
|
2001-09-28 |
2005-10-13 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of macromolecules
|
US20050233003A1
(en)
*
|
2001-09-28 |
2005-10-20 |
Solubest Ltd. |
Hydrophilic dispersions of nanoparticles of inclusion complexes of salicylic acid
|
DE10154464B4
(de)
*
|
2001-11-08 |
2005-10-20 |
Max Delbrueck Centrum |
Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
|
PT1443900E
(pt)
*
|
2001-11-13 |
2012-08-01 |
Celator Pharmaceuticals Inc |
Composições de veículo lipídico com estabilidade melhorada no sangue
|
US7700851B2
(en)
*
|
2001-11-13 |
2010-04-20 |
U.S. Smokeless Tobacco Company |
Tobacco nicotine demethylase genomic clone and uses thereof
|
US7351542B2
(en)
|
2002-05-20 |
2008-04-01 |
The Regents Of The University Of California |
Methods of modulating tubulin deacetylase activity
|
EA200401565A1
(ru)
*
|
2002-05-24 |
2005-04-28 |
Неофарм, Инк. |
Способ получения кардиолипина или аналога кардиолипина (варианты), способ получения липосомы и композиция кардиолипина для лечения заболеваний (варианты)
|
EP1513853A2
(de)
*
|
2002-05-24 |
2005-03-16 |
Neopharm, Inc. |
Cardiolipin- zusamensetzungen, verfahren zu deren herstellung und verwendung
|
DE60329497D1
(de)
|
2002-06-26 |
2009-11-12 |
Medigene Ag |
Herstellung einer kationisch liposomalen zubereitung, einen lipophilen wirkstoff enthaltend
|
AR036316A1
(es)
*
|
2002-08-29 |
2004-08-25 |
Monte Verde S A |
Una composicion farmaceutica de liposomas de tamano pequeno y metodo de preparacion
|
US20040127976A1
(en)
*
|
2002-09-20 |
2004-07-01 |
Conor Medsystems, Inc. |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
US20050277611A1
(en)
*
|
2002-10-16 |
2005-12-15 |
Neopharm, Inc. |
Cationic cardiolipin analoges and its use thereof
|
WO2004043363A2
(en)
*
|
2002-11-06 |
2004-05-27 |
Azaya Therapeutics, Inc. |
Protein-stabilized liposomal formulations of pharmaceutical agents
|
EP2135867B1
(de)
|
2002-11-07 |
2013-09-25 |
Kosan Biosciences Incorporated |
Trans-9,10-Dehydroepothilon C und trans-9,10-dehydroepothilon D, Analoga davon und Verfahren zu deren Herstellung
|
WO2004069224A2
(en)
*
|
2003-02-03 |
2004-08-19 |
Neopharm, Inc. |
Stable sterile filterable liposomal encapsulated taxane and other antineoplastic drugs
|
AU2004226327A1
(en)
|
2003-03-28 |
2004-10-14 |
Innovational Holdings, Llc |
Implantable medical device with beneficial agent concentration gradient
|
US7517342B2
(en)
|
2003-04-29 |
2009-04-14 |
Boston Scientific Scimed, Inc. |
Polymer coated device for electrically medicated drug delivery
|
WO2005016241A2
(en)
|
2003-05-16 |
2005-02-24 |
Intermune, Inc. |
Synthetic chemokine receptor ligands and methods of use thereof
|
US7691838B2
(en)
*
|
2003-05-30 |
2010-04-06 |
Kosan Biosciences Incorporated |
Method for treating diseases using HSP90-inhibiting agents in combination with antimitotics
|
US20050026893A1
(en)
*
|
2003-05-30 |
2005-02-03 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with immunosuppressants
|
US20050054625A1
(en)
*
|
2003-05-30 |
2005-03-10 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with nuclear export inhibitors
|
US20050020557A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with enzyme inhibitors
|
US20050020534A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with antimetabolites
|
US20050020556A1
(en)
*
|
2003-05-30 |
2005-01-27 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with platinum coordination complexes
|
US20050054589A1
(en)
*
|
2003-05-30 |
2005-03-10 |
Kosan Biosciences, Inc. |
Method for treating diseases using HSP90-inhibiting agents in combination with antibiotics
|
US7169179B2
(en)
*
|
2003-06-05 |
2007-01-30 |
Conor Medsystems, Inc. |
Drug delivery device and method for bi-directional drug delivery
|
US20060078560A1
(en)
*
|
2003-06-23 |
2006-04-13 |
Neopharm, Inc. |
Method of inducing apoptosis and inhibiting cardiolipin synthesis
|
US7785653B2
(en)
*
|
2003-09-22 |
2010-08-31 |
Innovational Holdings Llc |
Method and apparatus for loading a beneficial agent into an expandable medical device
|
WO2005040758A2
(en)
*
|
2003-10-24 |
2005-05-06 |
Intermune, Inc. |
Use of pirfenidone in therapeutic regimens
|
WO2005065677A1
(ja)
*
|
2004-01-09 |
2005-07-21 |
Otsuka Pharmaceutical Factory, Inc. |
パクリタキセルまたはドセタキセルを溶解または分散させるための脂肪乳剤
|
WO2005065676A1
(ja)
*
|
2004-01-09 |
2005-07-21 |
Otsuka Pharmaceutical Factory, Inc. |
パクリタキセルまたはドセタキセルを含む脂肪乳剤
|
NZ548195A
(en)
*
|
2004-01-14 |
2011-01-28 |
Gilead Sciences Inc |
Lipid-based dispersions useful for drug delivery
|
EP1737444A4
(de)
|
2004-03-05 |
2008-05-21 |
Univ Florida State Res Found |
C7-lactyloxa-substituierte taxane
|
US7659310B2
(en)
*
|
2004-04-27 |
2010-02-09 |
Formatech, Inc. |
Methods of enhancing solubility of agents
|
US7345093B2
(en)
*
|
2004-04-27 |
2008-03-18 |
Formatech, Inc. |
Methods of enhancing solubility of compounds
|
JP2008513356A
(ja)
*
|
2004-08-09 |
2008-05-01 |
アリオス バイオファーマ インク. |
合成高度糖鎖付加プロテアーゼ耐性ポリペプチド変異体、それを使用する経口製剤および方法
|
US7597884B2
(en)
|
2004-08-09 |
2009-10-06 |
Alios Biopharma, Inc. |
Hyperglycosylated polypeptide variants and methods of use
|
US8557861B2
(en)
*
|
2004-09-28 |
2013-10-15 |
Mast Therapeutics, Inc. |
Low oil emulsion compositions for delivering taxoids and other insoluble drugs
|
WO2006089209A2
(en)
*
|
2005-02-17 |
2006-08-24 |
The Board Of Trustees Of The Leland Stanford Junior University |
Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby
|
US20080102111A1
(en)
*
|
2005-03-09 |
2008-05-01 |
Hiromichi Imanaka |
Anticancer Composition for Oral Use Comprising Liposome Containing Phytosterols and Prevention or Treatment for Cancer Using the Liposome
|
US20060239925A1
(en)
*
|
2005-04-21 |
2006-10-26 |
Konica Minolta Medical & Graphic, Inc. |
Method of manufacturing pharmaceutical preparation containing liposomes
|
KR20080007642A
(ko)
*
|
2005-04-29 |
2008-01-22 |
코산 바이오사이언시즈, 인코포레이티드 |
프로테아좀 억제제와 함께 17-aag 또는 17-ag 또는 둘중 하나의 전구약물을 사용하여 다발성 골수종을 치료하는방법
|
EP1874296A4
(de)
*
|
2005-04-29 |
2010-06-30 |
Kosan Biosciences Inc |
Verfahren zur behandlung mehrerer myelome mithilfe von 17-aag oder 17-ag oder eines prodrugs oder von allem
|
EP1896007B1
(de)
|
2005-05-04 |
2014-03-19 |
Medigene AG |
Verfahren zur verabreichung einer katonischen zubereitung aus liposomen, welche paclitaxel enthält
|
TWI376239B
(en)
*
|
2006-02-01 |
2012-11-11 |
Andrew Xian Chen |
Vitamin e succinate stabilized pharmaceutical compositions, methods for the preparation and the use thereof
|
CA2922029C
(en)
*
|
2006-03-22 |
2017-11-28 |
Medigene Ag |
A combination of a cationic liposomal preparation comprising an antimitotic agent and a non-liposomal preparation comprising an antimitotic agent
|
US20100068251A1
(en)
*
|
2006-10-10 |
2010-03-18 |
Jina Pharmaceuticals, Inc. |
Aqueous Systems For The Preparation Of Lipid Based Pharmaceutical Compounds; Compositions, Methods, And Uses Thereof
|
CA2669355C
(en)
*
|
2006-11-06 |
2012-10-30 |
Jina Pharmaceuticals, Inc. |
Guggulphospholipid methods and compositions
|
US20080124387A1
(en)
*
|
2006-11-27 |
2008-05-29 |
Kapac, Llc |
Methods and formulations for enhancing the absorption and decreasing the absorption variability of orally administered drugs, vitamins and nutrients
|
KR20080101056A
(ko)
*
|
2007-05-15 |
2008-11-21 |
한국화학연구원 |
지질나노입자를 포함하는 디테르페노이드 알칼로이드계약물 용액 및 이의 제조방법
|
WO2009006613A1
(en)
|
2007-07-03 |
2009-01-08 |
Children's Hospital & Research Center At Oakland |
Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting
|
JP2010532756A
(ja)
*
|
2007-07-06 |
2010-10-14 |
オーエスアイ・ファーマスーティカルズ・インコーポレーテッド |
mTORC1及びmTORC2の両方の阻害剤を含む組み合わせ抗癌療法
|
US20090088393A1
(en)
*
|
2007-09-28 |
2009-04-02 |
Zomanex, Llc |
Methods and formulations for converting intravenous and injectable drugs into oral dosage forms
|
FR2922107B1
(fr)
*
|
2007-10-10 |
2010-02-26 |
Aventis Pharma Sa |
Nouvelles compositions a base de taxoides
|
WO2009143454A2
(en)
|
2008-05-22 |
2009-11-26 |
Kereos, Inc. |
Combination antitumor therapy
|
WO2010005850A1
(en)
|
2008-07-08 |
2010-01-14 |
The J. David Gladstone Institutes |
Methods and compositions for modulating angiogenesis
|
JP2012502048A
(ja)
|
2008-09-08 |
2012-01-26 |
ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ |
アルデヒドデヒドロゲナーゼ活性のモジュレーターおよびその使用方法
|
EP2349279A4
(de)
|
2008-10-28 |
2013-12-25 |
Univ Leland Stanford Junior |
Aldehyddehydrogenase-modulatoren und anwendungsverfahren dafür
|
US8541360B2
(en)
*
|
2008-11-19 |
2013-09-24 |
Ben Venue Laboratories, Inc. |
Parenteral formulations comprising sugar-based esters and ethers
|
US10143652B2
(en)
|
2009-09-23 |
2018-12-04 |
Curirx Inc. |
Methods for the preparation of liposomes
|
WO2011038073A1
(en)
|
2009-09-23 |
2011-03-31 |
Formatech, Inc. |
Methods for the preparation of liposomes comprising docetaxel
|
TWI438009B
(zh)
*
|
2010-02-19 |
2014-05-21 |
Teikoku Pharma Usa Inc |
紫杉烷前-乳劑調配物及其製造與使用之方法
|
JP5824511B2
(ja)
|
2010-05-03 |
2015-11-25 |
テイコク ファーマ ユーエスエー インコーポレーテッド |
非水タキサンプロエマルジョン配合物ならびにそれを調製および使用する方法
|
US10457659B2
(en)
|
2011-04-29 |
2019-10-29 |
The Board Of Trustees Of The Leland Stanford Junior University |
Compositions and methods for increasing proliferation of adult salivary stem cells
|
KR102165464B1
(ko)
|
2012-07-19 |
2020-10-14 |
레드우드 바이오사이언스 인코포레이티드 |
Cd22에 대해 특이적인 항체 및 이들의 사용 방법
|
JO3685B1
(ar)
|
2012-10-01 |
2020-08-27 |
Teikoku Pharma Usa Inc |
صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
|
WO2014074218A1
(en)
|
2012-11-12 |
2014-05-15 |
Redwood Bioscience, Inc. |
Compounds and methods for producing a conjugate
|
US20150368342A1
(en)
|
2013-02-15 |
2015-12-24 |
The Regents Of The University Of California |
Chimeric antigen receptor and methods of use thereof
|
EP2970124B1
(de)
|
2013-03-14 |
2019-05-22 |
The Board of Trustees of the Leland Stanford Junior University |
Mitochondriale aldehyd-dehydrogenase-2-modulatoren und verfahren zur verwendung davon
|
WO2015081282A1
(en)
|
2013-11-27 |
2015-06-04 |
Redwood Bioscience, Inc. |
Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
|
KR102319882B1
(ko)
|
2014-02-19 |
2021-11-03 |
아비브 테라퓨틱스, 인크. |
암의 치료를 위한 폴리사이클릭 아미드와 결합하는 미토콘드리아 알데히드 탈수소효소 2 (aldh2) 및 그의 용도
|
SG11201607746QA
(en)
|
2014-03-21 |
2016-10-28 |
Abbvie Inc |
Anti-egfr antibodies and antibody drug conjugates
|
CN104225615B
(zh)
*
|
2014-09-24 |
2017-02-01 |
东南大学 |
一种紫杉醇类磷脂化合物、其药物组合物及应用
|
KR20180053676A
(ko)
*
|
2015-09-16 |
2018-05-23 |
디에프비 소리아, 엘엘씨 |
약물 나노입자 전달체 및 이의 제조방법
|
US10654875B2
(en)
|
2015-11-12 |
2020-05-19 |
The Board Of Trustees Of The Leland Stanford Junior University |
Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
|
EP3377523A4
(de)
|
2015-11-19 |
2019-06-19 |
The Regents of The University of California |
Konditionell reprimierbare immunzellenrezeptoren und verfahren zur verwendung davon
|
TWI760319B
(zh)
|
2015-12-30 |
2022-04-11 |
杏國新藥股份有限公司 |
乳癌治療
|
JP6697541B2
(ja)
*
|
2016-01-07 |
2020-05-20 |
ウエスタン ユニバーシティ オブ ヘルス サイエンシーズ |
膀胱癌処置のための処方物
|
CN107158395B
(zh)
*
|
2016-03-07 |
2020-04-07 |
中国科学院上海药物研究所 |
一种卡巴他赛磷脂组合物及其制备方法和应用
|
EP3231421A1
(de)
|
2016-04-11 |
2017-10-18 |
Greenaltech, S.L. |
Verwendungen eines carotenoids bei der behandlung oder prävention von durch stress verursachten störungen
|
WO2017189432A1
(en)
|
2016-04-26 |
2017-11-02 |
R.P. Scherer Technologies, Llc |
Antibody conjugates and methods of making and using the same
|
DK3463308T3
(da)
|
2016-06-01 |
2022-01-31 |
Servier Ip Uk Ltd |
Formuleringer af polyalkylenoxid-asparaginase og fremgangsmåder til fremstilling og anvendelse deraf
|
AU2017277916A1
(en)
|
2016-06-08 |
2019-01-03 |
Abbvie Inc. |
Anti-CD98 antibodies and antibody drug conjugates
|
BR112018075626A2
(pt)
|
2016-06-08 |
2019-03-19 |
Abbvie Inc. |
anticorpos anti-b7-h3 e conjugados de fármaco anticorpo
|
JP2019521973A
(ja)
|
2016-06-08 |
2019-08-08 |
アッヴィ・インコーポレイテッド |
抗bh7−h3抗体及び抗体薬物コンジュゲート
|
BR112018075653A2
(pt)
|
2016-06-08 |
2019-08-27 |
Abbvie Inc |
anticorpos anti-b7-h3 e conjugados anticorpo fármaco
|
JP2019524651A
(ja)
|
2016-06-08 |
2019-09-05 |
アッヴィ・インコーポレイテッド |
抗cd98抗体及び抗体薬物コンジュゲート
|
TW201825087A
(zh)
|
2017-01-05 |
2018-07-16 |
杏國新藥股份有限公司 |
胰臟癌治療
|
AU2018211081A1
(en)
|
2017-01-18 |
2019-07-18 |
Bioatla, Inc. |
Chimeric antigen receptors against Axl or Ror2 and methods of use thereof
|
EP3388082A1
(de)
|
2017-04-13 |
2018-10-17 |
Galera Labs, LLC |
Kombinationskrebsimmuntherapie mit makrocyclischem pentaaza-ringkomplex
|
JP2021512110A
(ja)
|
2018-01-31 |
2021-05-13 |
ガレラ・ラブス・リミテッド・ライアビリティ・カンパニーGalera Labs, Llc |
ペンタアザ大環状環複合体および白金を基にした抗癌剤による組み合わせ癌療法
|
AU2019252676A1
(en)
|
2018-04-11 |
2020-11-26 |
Ohio State Innovation Foundation |
Methods and compositions for sustained release microparticles for ocular drug delivery
|
CN108721644B
(zh)
*
|
2018-06-05 |
2021-06-08 |
常州金远药业制造有限公司 |
一种紫杉烷类药物脂质体制备方法
|
EP3823674A4
(de)
|
2018-07-18 |
2022-12-28 |
Manzanita Pharmaceuticals, Inc. |
Konjugate zur abgabe eines krebsmittels an nervenzellen, verwendungsverfahren und verfahren zu deren herstellung
|
BR112021019701A2
(pt)
|
2019-04-02 |
2021-12-14 |
Kenjockety Biotechnology Inc |
Anticorpos multiespecíficos para antígeno de câncer de bomba de efluxo e composições, reagentes, kits e métodos relacionados aos mesmos
|
KR20220133884A
(ko)
|
2020-01-29 |
2022-10-05 |
켄조케티 바이오테크놀러지 인코포레이티드 |
항-mdr1 항체 및 이의 용도
|
EP4161564A1
(de)
|
2020-06-04 |
2023-04-12 |
Kenjockety Biotechnology, Inc. |
Multispezifische antikörper gegen abcg2-effluxpumpen-krebsantigen und zusammensetzungen, reagenzien, kits und verfahren im zusammenhang damit
|
AU2021284240A1
(en)
|
2020-06-04 |
2022-12-08 |
Kenjockety Biotechnology, Inc. |
Anti-ABCG2 antibodies and uses thereof
|
WO2022051390A1
(en)
|
2020-09-02 |
2022-03-10 |
Kenjockety Biotechnology, Inc. |
Anti-abcc1 antibodies and uses thereof
|
WO2022103603A1
(en)
|
2020-11-13 |
2022-05-19 |
Kenjockety Biotechnology, Inc. |
Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
|
US11980636B2
(en)
|
2020-11-18 |
2024-05-14 |
Jazz Pharmaceuticals Ireland Limited |
Treatment of hematological disorders
|
AR124681A1
(es)
|
2021-01-20 |
2023-04-26 |
Abbvie Inc |
Conjugados anticuerpo-fármaco anti-egfr
|
AU2022413942A1
(en)
|
2021-12-13 |
2024-05-30 |
William Robert Arathoon Living Trust |
Anti-abcb1 antibodies
|
WO2023159220A1
(en)
|
2022-02-18 |
2023-08-24 |
Kenjockety Biotechnology, Inc. |
Anti-cd47 antibodies
|